相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
Leonard B. Seeff et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C
Marc G. Ghany et al.
GASTROENTEROLOGY (2010)
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
Robert J. Fontana et al.
GUT (2010)
Prognostic Value of Ishak Fibrosis Stage: Findings from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
James E. Everhart et al.
HEPATOLOGY (2010)
The relationship between liver disease stage and liver fibrosis: a tangled web
Giacomo Germani et al.
HISTOPATHOLOGY (2010)
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial
G. T. Everson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C
J. O. Smith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
Thierry Poynard et al.
GASTROENTEROLOGY (2009)
The clinical use of HVPG measurements in chronic liver disease
Jaime Bosch et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock
Paul J. Matheson et al.
SURGERY (2009)
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the hepatitis C anti-viral long-term treatment against cirrhosis trial
G. T. Everson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Colchicine versus PEG-interferon alfa 2b long term therapy: Results of the 4 year copilot trial
N. H. Afdhal et al.
JOURNAL OF HEPATOLOGY (2008)
Non-invasive evaluation of liver fibrosis using transient elastography
Laurent Castera et al.
JOURNAL OF HEPATOLOGY (2008)
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
G. Lalazar et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies
Robert P. Myers et al.
LIVER INTERNATIONAL (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Changing trends in hepatitis C-related mortality in the United States, 1995-2004
Matthew Wise et al.
HEPATOLOGY (2008)
FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: A systematic review of diagnostic test accuracy
Abdel Aziz M. Shaheen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt
G. T. Everson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies
Jee-Fu Huang et al.
GUT (2007)
Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital
D. van der Poorten et al.
INTERNAL MEDICINE JOURNAL (2006)
Liver disease selectively modulates cytochrome P450-mediated metabolism
Reginald F. Frye et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study
Luigi Addario et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Chronic hepatitis C in patients with persistently normal alanine transaminase levels
Mitchell L. Shiffman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications
TI Huo et al.
CLINICAL TRANSPLANTATION (2006)
Global challenges in liver disease
Roger Williams
HEPATOLOGY (2006)
Significance of the minor cytochrome P450 3A isoforms
AK Daly
CLINICAL PHARMACOKINETICS (2006)
Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease
AJ Sanyal
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Evolution of the HALT-C trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders
WM Lee et al.
CONTROLLED CLINICAL TRIALS (2004)
Practices of liver biopsy in France: Results of a prospective nationwide survey
JF Cadranel et al.
HEPATOLOGY (2000)
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
M Malinchoc et al.
HEPATOLOGY (2000)
The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
GL Armstrong et al.
HEPATOLOGY (2000)
分享论文
